2021 annual financial data

Barinthus Biotherapeutics 2021 Net margin

Direct answer

Net margin was -18,979.48%.

Operating income was -45,221,000 USD and net income was -50,865,000 USD.
Operating cash flow was -32,583,000 USD.

Get free Barinthus Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
268,000 USD
Operating income
-45,221,000 USD
Net income
-50,865,000 USD
Operating cash flow
-32,583,000 USD